Desmopressin Toxicity Due to Prolonged Half-Life in 18 Patients With Nocturnal Enuresis

Journal of Urology

Volumn 176, Issue 2, 2006, Pages 754-758

  Dehoorne, Jo L ^a   Raes, Ann M ^a   van Laecke, Erik ^a   Hoebeke, Piet ^a   Vande Walle, Johan G ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

bladder; deamino arginine vasopressin; enuresis; half life; toxicity

Indexed keywords

DESMOPRESSIN ACETATE;

ABDOMINAL PAIN; ADOLESCENT; AEROSOL; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; CONVULSION; DIURESIS; DRUG ACTIVITY; DRUG HALF LIFE; DRUG INDUCED HEADACHE; DRUG URINE LEVEL; FEMALE; HUMAN; HYPONATREMIA; MALE; NAUSEA; NOCTURNAL ENURESIS; PRIORITY JOURNAL; SEIZURE; SIDE EFFECT; VOMITING; WATER INTOXICATION;

ADOLESCENT; ANTIDIURETIC AGENTS; CHILD; DEAMINO ARGININE VASOPRESSIN; ENURESIS; FEMALE; HALF-LIFE; HUMANS; MALE; PROSPECTIVE STUDIES; TIME FACTORS; WATER INTOXICATION;

EID: 33745228785     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(06)00299-0     Document Type: Article

References (18)

1. Nørgaard J.P., Pedersen E.B., and Djurhuus J.C. Diurnal anti-diuretic-hormone levels in enuretics. J Urol 134 (1985) 1029
2. Moffatt M.E., Harlos S., Kirshen A.J., and Burd L. Desmopressin acetate and nocturnal enuresis. how much do we know?. Pediatrics 92 (1993) 420
3. Hjalmas K., Arnold T., Bower W., Caione P., Chiozza L.M., and von Gontard A. Nocturnal enuresis. an international evidence based management strategy. J Urol 171 (2004) 2545
4. Hjälmas K., Hanson E., Hellstorm A.L., Kruse S., Sillen U., and Swedish Enuresis Trial (SWEET) group. Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis. an open multicentre study. Br J Urol 82 (1998) 704
5. Hjälmas K., and Bengtsson B. Efficacy, safety and dosing of desmopressin for nocturnal enuresis in Europe. Clin Pediatr (Spec Ed) (1993) 19
6. Van Kerrebroeck P.E. Experience with the long-term use of desmopressin for nocturnal enuresis in children and adolescents. BJU Int 89 (2002) 420
7. Beach P.S., Beach R.A., and Smith L.R. Hyponatremic seizures in a child treated with desmopressin to control enuresis. Clin Pediatr 9 (1993) 566
8. Shindel A., Tobin G., and Klutke C. Hyponatremia associated with desmopressin for the treatment of nocturnal polyuria. Urology 60 (2002) 344
9. Robson W.L., and Leung A.K. Side effects and complications of treatment with desmopressin for enuresis. J Natl Med Assoc 86 (1994) 775
10. Koff S.A. Estimating bladder capacity in children. Urology 21 (1983) 248
11. Andersson K.E., Bengtsson B., and Paulsen O. Desamino-8-D-arginine vasopressin (DDAVP). pharmacology and clinical use. Drugs Today 24 (1988) 509
12. Becker D.J., and Foley Jr. T.P. 1-Deamino-8D-arginine vasopressin the treatment of central diabetes insipidus in childhood. J Pediatr 92 (1978) 1011
13. Birkásova M., Birkás O., Flynn M.J., and Cort J.H. Desmopressin in the management of nocturnal enuresis in children. a double blind study. Pediatrics 62 (1978) 970
14. Fjellestad-Paulsen A., Hoglund P., Lundin S., and Paulsen O. Pharmacokinetics of 1-desamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers. Clin Endocrinol (Oxf) 38 (1993) 177
15. Terho P. Desmopressin in nocturnal enuresis. J Urol 145 (1991) 818
16. Robson W.L., Nørgaard J.P., and Leung A.K. Hyponatremia in patients with nocturnal enuresis treated with DDAVP. Eur J Pediatr 155 (1996) 959
17. Kallio J., Rautava P., and Huupponen R. Severe hyponatremia caused by intranasal desmopressin for nocturnal enuresis. Acta Paediatr 82 (1993) 881
18. Harris A.S., Nilsson I.M., Wagner Z.G., and Alkner U. Intranasal administration of peptides. nasal deposition, biological response, and absorption of desmopressin. J Pharmacol Sci 75 (1986) 1085